Interaction between α-Synuclein and Other Proteins in Neurodegenerative Disorders

被引:57
|
作者
Jellinger, Kurt A. [1 ]
机构
[1] Inst Clin Neurobiol, A-1070 Vienna, Austria
来源
THESCIENTIFICWORLDJOURNAL | 2011年 / 11卷
关键词
neurodegeneration; alzheimer disease; parkinson disease; protein interaction; coformer seeding; pathogenesis; BETA-AMYLOID PEPTIDES; SPORADIC PARKINSONS-DISEASE; MULTIPLE SYSTEM ATROPHY; AMYGDALA LEWY BODIES; TAU-TRANSGENIC MICE; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; EXTRAPYRAMIDAL SIGNS; ANIMAL-MODELS;
D O I
10.1100/2011/371893
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Protein aggregation is a common characteristic of many neurodegenerative disorders, and the interaction between pathological/toxic proteins to cause neurodegeneration is a hot topic of current neuroscience research. Despite clinical, genetic, and experimental differences, evidence increasingly indicates considerable overlap between synucleinopathies and tauopathies or other protein-misfolding diseases. Inclusions, characteristics of these disorders, also occurring in other neurodegenerative diseases, suggest interactions of pathological proteins engaging common downstream pathways. Novel findings that have shifted our understanding in the role of pathologic proteins in the pathogenesis of Parkinson and Alzheimer diseases have confirmed correlations/overlaps between these and other neurodegenerative disorders. The synergistic effects of alpha-synuclein, hyperphosphorylated tau, amyloid-beta, and other pathologic proteins, and the underlying molecular pathogenic mechanisms, including induction and spread of protein aggregates, are critically reviewed, suggesting a dualism or triad of neurodegeneration in protein-misfolding disorders, although the etiology of most of these processes is still mysterious.
引用
收藏
页码:1893 / 1907
页数:15
相关论文
共 50 条
  • [1] Interaction between pathogenic proteins in neurodegenerative disorders
    Jellinger, Kurt A.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2012, 16 (06) : 1166 - 1183
  • [2] α-Synuclein in Parkinson disease and other neurodegenerative disorders
    Eller, Michael
    Williams, David R.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (03) : 403 - 408
  • [3] Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders
    Krüger, R
    Müller, T
    Riess, O
    JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (01) : 31 - 40
  • [4] Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders
    R. Krüger
    T. Müller
    O. Riess
    Journal of Neural Transmission, 2000, 107 : 31 - 40
  • [5] Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders
    Wang, Zheng-Yu
    Han, Zhen-Min
    Liu, Qi-Fei
    Tang, Wei
    Ye, Kui
    Yao, Yu-You
    INTERNATIONAL PSYCHOGERIATRICS, 2015, 27 (09) : 1429 - 1438
  • [6] Interaction of misfolded proteins and mitochondria in neurodegenerative disorders
    Abramov, Andrey Y.
    Berezhnov, Alexey V.
    Fedotova, Evgeniya I.
    Zinchenko, Valery P.
    Dolgacheva, Ludmila P.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2017, 45 : 1025 - 1033
  • [7] Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders
    Li, Xuling
    James, Simon
    Lei, Peng
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2016, 60 (03) : 298 - 304
  • [8] Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders
    Xuling Li
    Simon James
    Peng Lei
    Journal of Molecular Neuroscience, 2016, 60 : 298 - 304
  • [9] α-synuclein gene dosage study in individuals with parkinsonian syndromes and other neurodegenerative disorders
    Bech, S.
    Norremolle, A.
    Svenstrup, K.
    Winge, K.
    Nielsen, J. E.
    Hjermind, L. E.
    MOVEMENT DISORDERS, 2009, 24 : S135 - S135
  • [10] Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders
    Shan, Frank Y.
    Fung, Kar-Ming
    Zieneldien, Tarek
    Kim, Janice
    Cao, Chuanhai
    Huang, Jason H.
    LIFE-BASEL, 2021, 11 (11):